Streetbeat News

Regulatory

OLMA

Olema Oncology announced it will present new clinical data on Palazestrant in combination with CDK4/6 inhibitors at the 2023 San Antonio Breast Cancer Symposium. This could indicate progress in their treatment development for breast cancer.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 10:11 pm

BRK-A

BRK-B

Charlie Munger, the renowned investor and Warren Buffett's business partner at Berkshire Hathaway Inc, has passed away at 99. Munger was a vocal critic of Bitcoin, expressing concerns over its volatility, lack of regulation, and use in illegal activities. Despite acknowledging Bitcoin's success, he remained critical of cryptocurrencies, calling for a U.S. ban and labeling them as 'disgusting and contrary to the interests of civilization.' Munger's death is seen as the end of an era in finance, with his views on Bitcoin sparking debates within the financial community.

Portfolio Pulse from Murtuza Merchant

November 28, 2023 | 10:07 pm

VCXB

10X Capital Venture Acquisition Corp. III (VCXB) received a notice from NYSE for not filing its Q3 Form 10-Q on time. The delay was due to the accounting firm requiring more time to review financial statements. VCXB has since filed the report and regained compliance with NYSE listing standards.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 9:26 pm

CCI

Elliott Investment Management L.P., managing funds with a $2 billion investment in Crown Castle Inc. (CCI), has submitted a Section 220 demand to inspect CCI's books and records. This follows CCI's adoption of bylaw amendments that Elliott views as shareholder-unfriendly and a breach of fiduciary duties by CCI's Board. Elliott criticizes the 'Acting in Concert' provisions, which they believe disenfranchise shareholders and are prohibited under Delaware law. Elliott calls for the reconstitution of CCI's Board with directors committed to best-in-class governance.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 9:24 pm

MNTN

Everest Consolidator Acquisition Corporation received a notice from the NYSE for not filing its Q3 Form 10-Q on time, violating the Listing Rule. The company has six months to file and regain compliance, with a possible six-month extension. The delay was due to internal resource constraints and issues with the use of restricted funds. The company is working to complete the Form 10-Q and intends to file it as soon as possible.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 9:24 pm

WTER

The Alkaline Water Company Inc. received a deficiency letter from Nasdaq for not filing its Form 10-Q on time, which is an additional basis for potentially delisting its securities. The company has appealed to the Hearings Panel and is working to regain compliance. There is no assurance of maintaining its Nasdaq listing, and if delisted, the stock may trade on the OTC Markets Group.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 9:24 pm

FUV

Arcimoto, Inc. (FUV) received a notice from Nasdaq on November 22, 2023, for not filing its Q3 report on time, violating Nasdaq Listing Rule 5250(c)(1). The delay has no immediate effect on its stock's listing or trading, but continued delays could impact it. Arcimoto must submit a compliance plan by January 22, 2024, and file the overdue report by May 20, 2024. The company plans to file the report as soon as possible.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 9:22 pm

CPTK

Crown PropTech Acquisitions (CPTK) received a notice from the NYSE for not filing its Q3 Form 10-Q on time. The company has six months from November 20, 2023, to file and regain compliance. Failure to do so may lead to delisting proceedings. CPTK had filed a Form 12b-25 on November 14, 2023, indicating a delay but missed the extended deadline. The company is working to complete the review of its financial statements for accurate disclosure.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 9:21 pm

MAXN

Maxeon Solar Technologies, Ltd. (NASDAQ:MAXN) has initiated an investigation into potential patent infringements related to its TOPCon solar cell technology in the U.S. The company is monitoring the market for products that may infringe on its extensive patent portfolio, which includes over 1,600 granted patents and 360 pending applications globally. Maxeon's Chief Legal & Sustainability Officer, Lindsey Wiedmann, emphasized the company's commitment to defending its intellectual property rights, citing previous lawsuits filed against Tongwei and Aiko for infringement of other technologies.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 9:20 pm

TRIB

Trinity Biotech has received a notice of non-compliance from Nasdaq regarding the minimum market value of publicly held shares required for continued listing on the Nasdaq Global Select Market. The company has a compliance period of 180 days to meet the minimum requirement, failing which it may be subject to delisting procedures.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 9:09 pm